Astrazeneca Plc Earnings

Astrazeneca Plc’s revenue jumped 11.74% since last year same period to $14457Mn in the Q2 2025. On a quarterly growth basis, Astrazeneca Plc has generated 6.4% jump in its revenue since last 3-months.

Astrazeneca Plc’s net profit jumped 27.14% since last year same period to $2450Mn in the Q2 2025. On a quarterly growth basis, Astrazeneca Plc has generated -15.98% fall in its net profits since last 3-months.

Astrazeneca Plc’s net profit margin jumped 13.78% since last year same period to 16.95% in the Q2 2025. On a quarterly growth basis, Astrazeneca Plc has generated -21.03% fall in its net profit margins since last 3-months.

Astrazeneca Plc’s price-to-earnings ratio after this Q2 2025 earnings stands at 29.95.

Astrazeneca Plc’s earning per share (EPS) estimates for the current quarter stand at 1.14 - a 4.59% jump from last quarter’s estimates.

Astrazeneca Plc’s earning per share (EPS) estimates for the current year stand at 1.14.

Astrazeneca Plc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Astrazeneca Plc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Astrazeneca Plc declared 0.52 dividend per share during the earnings announcement for Q3 2025.